Cleared Traditional

K864886 - RESPIGRAPH-RESPISOMNOGRAPH-RESPICENTRAL

K864886 is the FDA 510(k) clearance for RESPIGRAPH-RESPISOMNOGRAPH-RESPICENTRAL by Nims/Respitrace Corp.. It is a Class 2 Anesthesiology device (product code BZK) cleared through the Traditional 510(k) pathway after a 84-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1987
Decision
84d
Days
Class 2
Risk

K864886 is an FDA 510(k) clearance for the RESPIGRAPH-RESPISOMNOGRAPH-RESPICENTRAL. Classified as Spirometer, Monitoring (w/wo Alarm) (product code BZK), Class II - Special Controls.

Submitted by Nims/Respitrace Corp. (Washington, US). The FDA issued a Cleared decision on March 6, 1987 after a review of 84 days - a notably fast clearance cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1850 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Nims/Respitrace Corp. devices

Submission Details

510(k) Number K864886 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 12, 1986
Decision Date March 06, 1987
Days to Decision 84 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
56d faster than avg
Panel avg: 140d · This submission: 84d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code BZK Spirometer, Monitoring (w/wo Alarm)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1850
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - BZK Spirometer, Monitoring (w/wo Alarm)

All 10
Devices cleared under the same product code (BZK) and FDA review panel - the closest regulatory comparables to K864886.
Gas Module 3
K180788 · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · Oct 2018
ExSpiron 1Xi
K173181 · Respiratory Motion, Inc. · Mar 2018
GAS MODULE SE, MODEL 0998-00-0481-02
K062754 · Datascope Corp. · Nov 2006
OHMEDA 5410 VOLUME MONITOR
K862687 · Ohmeda Medical · Sep 1986
OHMEDA 5420 VOLUME MONITOR
K862688 · Ohmeda Medical · Sep 1986
OHMEDA RM311 RESPIROMETER
K843799 · Ohmeda Medical · Oct 1984